| scholarly article | Q13442814 |
| P50 | author | Inés Ibarra-Lecue | Q85532129 |
| P2093 | author name string | Benito Morentin | |
| Luis F Callado | |||
| J Javier Meana | |||
| Leyre Urigüen | |||
| Rebeca Diez-Alarcia | |||
| P2860 | cites work | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia | Q24299992 |
| Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine. | Q51731971 | ||
| Signaling Pathways Leading to Phosphorylation of Akt and GSK-3β by Activation of Cloned Human and Rat Cerebral D2and D3Receptors | Q51771315 | ||
| Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway | Q57647123 | ||
| Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families | Q80388450 | ||
| Association of AKT1 with schizophrenia confirmed in a Japanese population | Q80950862 | ||
| Pathology of white matter integrity in three major white matter fasciculi: A post-mortem study of schizophrenia and treatment status | Q91419114 | ||
| mTOR Expression in Hippocampus and Prefrontal Cortex Is Downregulated in a Rat Model of Schizophrenia Induced by Chronic Administration of Ketamine | Q92388202 | ||
| Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia | Q92732345 | ||
| An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior | Q24310712 | ||
| AKT/PKB signaling: navigating downstream | Q24657857 | ||
| Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function | Q26770762 | ||
| A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health | Q28118906 | ||
| Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits | Q28246677 | ||
| Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling | Q28373447 | ||
| Pten regulates neuronal arborization and social interaction in mice | Q28512488 | ||
| mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt | Q29547767 | ||
| mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists | Q29618120 | ||
| Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction | Q29618388 | ||
| Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence | Q29618819 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function | Q30458585 | ||
| Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. | Q30544800 | ||
| Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. | Q30819593 | ||
| Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants | Q33604879 | ||
| Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity | Q33777656 | ||
| Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder | Q33904544 | ||
| Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance | Q34466060 | ||
| Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk | Q34691699 | ||
| Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning | Q35130800 | ||
| Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions | Q35748119 | ||
| Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. | Q36470315 | ||
| Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: I. Remapping of Areas 9 and 46 using Quantitative Criteria | Q36684009 | ||
| The growing role of mTOR in neuronal development and plasticity. | Q36739424 | ||
| AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families | Q36739834 | ||
| 4E-BP1, a multifactor regulated multifunctional protein | Q36838384 | ||
| Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway | Q36864001 | ||
| Synaptic activation of ribosomal protein S6 phosphorylation occurs locally in activated dendritic domains | Q36935481 | ||
| Reduced protein synthesis in schizophrenia patient-derived olfactory cells | Q37058610 | ||
| Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins | Q37255974 | ||
| Optimal targeting of the mTORC1 kinase in human cancer | Q37398288 | ||
| Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade | Q37416273 | ||
| The DPYSL2 gene connects mTOR and schizophrenia. | Q37648236 | ||
| Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder? | Q37729341 | ||
| mTOR complexes in neurodevelopmental and neuropsychiatric disorders | Q38156016 | ||
| Is the mTOR-signalling cascade disrupted in Schizophrenia? | Q38165200 | ||
| Ribosomal Protein S6 Phosphorylation: Four Decades of Research | Q38651385 | ||
| The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia | Q38803633 | ||
| Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms. | Q38990216 | ||
| Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. | Q40097564 | ||
| GSK-3 parameters in lymphocytes of schizophrenic patients | Q40697511 | ||
| GSK3 as a Sensor Determining Cell Fate in the Brain | Q40963450 | ||
| The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 | ||
| Abnormalities of signal transduction networks in chronic schizophrenia | Q41195184 | ||
| Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia | Q41197010 | ||
| DNA damage and oxidative injury are associated with hypomyelination in the corpus callosum of newborn Nbn(CNS-del) mice | Q41931041 | ||
| Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. | Q42523266 | ||
| Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses | Q42527577 | ||
| Effects of neonatal MK-801 treatment on p70S6K-S6/eIF4B signal pathways and protein translation in the frontal cortex of the developing rat brain | Q43197670 | ||
| Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment | Q43299005 | ||
| Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. | Q43579199 | ||
| Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy | Q44329097 | ||
| Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia | Q44743796 | ||
| Genetic association of the AKT1 gene with schizophrenia in a British population | Q45035942 | ||
| Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats. | Q45068239 | ||
| Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum | Q45287391 | ||
| Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease | Q45295751 | ||
| Synaptically driven phosphorylation of ribosomal protein S6 is differentially regulated at active synapses versus dendrites and cell bodies by MAPK and PI3K/mTOR signaling pathways. | Q46703393 | ||
| The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex | Q46762612 | ||
| Ribosomal Protein S6 Phosphorylation Is Involved in Novelty-Induced Locomotion, Synaptic Plasticity and mRNA Translation | Q47222307 | ||
| Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density | Q47450317 | ||
| A unique homeostatic signaling pathway links synaptic inactivity to postsynaptic mTORC1. | Q47661497 | ||
| Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma. | Q47828172 | ||
| Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex | Q48120338 | ||
| Clozapine regulation of p90RSK and c-Fos signaling via the ErbB1-ERK pathway is distinct from olanzapine and haloperidol in mouse cortex and striatum | Q48300297 | ||
| Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia | Q48417385 | ||
| Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs | Q48493255 | ||
| Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. | Q48556742 | ||
| Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia | Q48591134 | ||
| Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction | Q48596589 | ||
| Low GSK-3 activity in frontal cortex of schizophrenic patients | Q48752142 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 344 | |
| P577 | publication date | 2020-03-24 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia | |
| P478 | volume | 11 |
| Q132042932 | Ribosomal Protein S6: A Potential Therapeutic Target against Cancer? | cites work | P2860 |
Search more.